1. Weidinger S, Novak N. Atopic dermatitis.Lancet. 2016;387(10023):1109-1122. doi:10.1016/S0140-6736(15)00149-X
2. Mozryska O. House dust mite sensitivity in atopic children with dectin-1 rs7309123 polymorphism. Alergologia Polska-Polish J Allergol. 2022; 9(3);191-195. doi:10.5114/pja.2022.119232
3. Silverberg JI, Barbarot S, Gadkari A, et al. Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study.Ann Allergy Asthma Immunol. 2021;126(4):417-428.e2. doi:10. 1016/j.anai.2020.12.020
4. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey.Allergy. 2018;73(6):1284-1293. doi:10.1111/all.13401
5. Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics.J Am Acad Dermatol. 2019;80(2):390-401. doi:10. 1016/j.jaad.2018.09.035
6. Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-9.e1-27. doi:10. 1016/j.jaci.2012.12.672
7. Di Bari F. Atopic dermatitis and alpha-chemokines. Clin Ter. 2015;166(3): e182-187. doi:10.7417/CT.2015.1852
8. Silverberg JI. Comorbidities and the impact of atopic dermatitis.Ann Allergy Asthma Immunol. 2019;123(2):144-151. doi:10.1016/j.anai.2019. 04.020
9. Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21(1):21-40. doi:10.1038/s41573-021-00266-6
10. Kim BE, Leung DY. Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res. 2018;10(3):207-215. doi:10. 4168/aair.2018.10.3.207
11. Furue M, Ulzii D, Vu YH, Tsuji G, Kido-Nakahara M, Nakahara T. Pathogenesis of atopic dermatitis: current paradigm. Iran J Immunol. 2019;16(2):97-107. doi:10.22034/IJI.2019.80253
12. Kolb L, Ferrer-Bruker SJ. Atopic dermatitis. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls. Publishing; 2022. Available from: https://www.ncbi.nlm.nih. gov/books/NBK448071/
13. Kezic S, O’Regan GM, Lutter R, et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol. 2012;129(4):1031-1039.e1. doi:10.1016/j.jaci.2011.12.989
14. Ozdin M. The relationship between hematological and allergic parameters in children with atopic dermatitis. Balıkesir Med J. 2020;4(3): 1-6. doi:10.33716/bmedj.760653
15. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561-570. doi:10.1111/j.1398-9995.2004.00476.x
16. Hamad DA, Aly MM, Abdelhameid MA, et al. Combined blood indexes of systemic inflammation as a mirror to admission to intensive care unit in COVID-19 patients: a multicentric study. J Epidemiol Glob Health. 2022;12(1):64-73. doi:10.1007/s44197-021-00021-5
17. Moldovan F, Gligor A, Moldovan L, Bataga T. The impact of the COVID-19 pandemic on the orthopedic residents: a pan-romanian survey.Int J Environ Res Public Health. 2022;19(15):9176. doi:10.3390/ijerph19159176
18. Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults.J Clin Med. 2023;12(3):1128. doi:10. 3390/jcm12031128
19. Hollis K, Proctor C, McBride D, et al. Comparison of urticaria activity score over 7days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study.Am J Clin Dermatol. 2018;19(2):267-274. doi:10.1007/s40257-017-0331-8
20. Guven DC, Sahin TK, Erul E, Kilickap S, Gambichler T, Aksoy S. The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis.Cancers (Basel). 2022; 14(11):2675. doi:10.3390/cancers14112675
21. Sari S, Soysal DG, Turkeli A. Atopik dermatit tanılı çocukların aile bireylerinde yaşam ve uyku kalitesinin değerlendirilmesi.Pam Tıp Derg. 2022;15(3):475-483. doi:10.31362/patd.1031195
22. Çömlek FÖ, Toprak A, Nursoy MA. Çocukluk çağı atopik dermatitli hastalarda ve ailelerinde dermatolojik yaşam kalitesi değerlendirilmesi.Türk Pediatri Arş,2020;55(3):270-276.
23. Ciğerci Günaydın N, Güler Ş, Yerlioğlu Ö, Öztürk M, Dınlamaz B, Samancı N. Atopik dermatitli hastalarda besin alerjisi sıklığının ve hastalık şiddetinin değerlendirilmesi. Pam Tıp Derg. 2021;14(4):878-885. doi:10.31362/patd.861596
24. Inokuchi-Sakata S, Ishiuji Y, Katsuta M, et al. Role of eosinophil relative count and neutrophil-to-lymphocyte ratio in the assessment of severity of atopic dermatitis.Acta Derm Venereol. 2021;101(7):adv00491. doi:10. 2340/00015555-3838
25. Dogru M, Citli R. The neutrophil-lymphocyte ratio in children with atopic dermatitis: a case-control study.Clin Ter. 2017;168(4):e262-e265. doi:10.7417/T.2017.2017
26. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11(1):55-59. doi:10.1586/erc.12.159
27. Söğütlü Y, Altaş U. Predictive value of neutrophil-lymphocyte ratio and other inflammation indices in febrile seizures in children.J Clin Med. 2024;13(17):5330. doi:10.3390/jcm13175330
28. Altas U, Unlu DA, Gulluce H, et al. Evaluation of the relationship between laboratory parameters and allergy tests in children with atopic dermatitis.Chron Precis Med Res. 2023;4(2):168-171. doi:10.5281/zenodo.8201981